Drug discovery and development is a high-risk, expensive endeavor and it commonly takes about 10− 15 years to obtain marketing approval from project inception. 1 Research efforts …
MALDI imaging mass spectrometry is a powerful analytical tool enabling the visualization of biomolecules in tissue. However, there are unique challenges associated with protein …
G Baquer, L Sementé, T Mahamdi… - Mass Spectrometry …, 2023 - Wiley Online Library
Mass spectrometry imaging (MSI) has become a widespread analytical technique to perform nonlabeled spatial molecular identification. The Achilles' heel of MSI is the annotation and …
Unraveling the complexity of biological systems relies on the development of new approaches for spatially resolved proteoform‐specific analysis of the proteome. Herein, we …
JL Nickerson, V Baghalabadi… - Mass Spectrometry …, 2023 - Wiley Online Library
Top‐down proteomics is emerging as a preferred approach to investigate biological systems, with objectives ranging from the detailed assessment of a single protein …
Over the last decade mass spectrometry imaging (MSI) has been integrated in to many areas of drug discovery and development. It can have significant impact in oncology drug …
K Davalieva, I Maleva Kostovska… - Frontiers in cellular …, 2016 - frontiersin.org
Despite intense scientific efforts, the neuropathology and pathophysiology of schizophrenia are poorly understood. Proteomic studies, by testing large numbers of proteins for …
Background Recently, it was demonstrated that proteins can be translated from alternative open reading frames (altORFs), increasing the size of the actual proteome. Top-down mass …
Tissue spatially-resolved proteomics was performed on 3 brain regions, leading to the characterization of 123 reference proteins. Moreover, 8 alternative proteins from alternative …